Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-087035
Filing Date
2024-04-04
Accepted
2024-04-04 14:07:04
Documents
12
Effectiveness Date
2024-04-04

Document Format Files

Seq Description Document Type Size
1 F-3ASR d820414df3asr.htm F-3ASR 342205
2 EX-1.1 d820414dex11.htm EX-1.1 159588
3 EX-4.1 d820414dex41.htm EX-4.1 421436
4 EX-5.1 d820414dex51.htm EX-5.1 8529
5 EX-5.2 d820414dex52.htm EX-5.2 10776
6 EX-23.1 d820414dex231.htm EX-23.1 1987
7 EX-23.2 d820414dex232.htm EX-23.2 2023
8 EX-25.1 d820414dex251.htm EX-25.1 4366497
9 EX-FILING FEES d820414dexfilingfees.htm EX-FILING FEES 33721
10 GRAPHIC g820414g0403073348218.jpg GRAPHIC 1714
11 GRAPHIC g820414g99a99.jpg GRAPHIC 27021
12 GRAPHIC g820414snap0002.jpg GRAPHIC 2002
  Complete submission text file 0001193125-24-087035.txt   5384729
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: F-3ASR | Act: 33 | File No.: 333-278506 | Film No.: 24822678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)